FDA advisers vote in favor of Biogen and Eisai’s collaborative Alzheimer’s treatment
If granted full FDA approval, which could come in early July, treatment could boost annual Medicare spending by nearly $9 billion, analysis shows.
Pharmaceutical
The latest pharmaceutical industry news from MarketWatch.
NY AG approves $17.3 billion opioid settlement with CVS, Walgreens, Teva and AbbVie’s Allergan
New York Attorney General Letitia James announced Friday the final approval of $17.3 billion in national settlement agreements with drug-store cha...
Mangoceuticals stock extends pullback from previous session’s intraday high
Shares of Mangoceuticals Inc. MGRX fell 6.7% in premarket trading, to extend their sharp pullback from the previous session’s intraday high. The stock had rocketed as much as 60.8% to an intraday high of $2.38 soon after T...
FDA advisers vote in favor of AstraZeneca, Sanofi antibody for infant RSV protection
Advisers to the U.S. Food and Drug Administration voted unanimously Thursday to recommend a monoclonal antibody developed by Sanofi SNY and AstraZeneca AZN to protect infants from respiratory syncytial virus. RSV is a comm...
Mangoceutical stock jumps on heavy volume after Barstool Sports sponsorship deal
Shares of Mangoceuticals Inc. MGRX skyrocketed as much as 60.8% intraday, before paring gains to be up 15.2% in very active afternoon trading, after the erectile dysfunction (ED) drug maker announced a sponsorship deal wit...
Teva concludes nationwide opioid settlement agreement, reaches separate settlement with Nevada
Teva Pharmaceuticals TEVA announced Thursday that it has resolved its nationwide settlement agreement related to opioid claims brought by states and reached a separate settlement with the state of Nevada. The company will ...
A ‘perfect business.’ Why investors may want to follow the Saudis into golf, says this strategist.
The Saudis are putting golf on the map in a big way and investors should be paying attention, says Bill Blain.
Most Popular
More Pharmaceutical News
Eisai shares rise as FDA memo raises hopes for full approval of Alzheimer’s drug
Eisai shares rose sharply Thursday morning after the U.S. Food and Drug Administration's review memo on Leqembi raised expectations for full approval of the Alzheimer's drug.
As AI advances in healthcare, industry players wrestle with its risks
Accuracy of health information, privacy and equity are among executives’ key concerns as health AI rapidly evolves.
Ozempic: Will Medicare cover this TikTok-trending weight loss and diabetes drug?
Ozempic, a medication used to treat Type 2 diabetes, has gone viral as a weight loss drug. Does Medicare pay for it? Here's when it does and doesn't.
Merck is suing the government over Medicare drug prices — what retirees need to know
Inflation Reduction Act provision was set to lower drug costs for millions of retirees
Merck lawsuit challenging Medicare drug price negotiation signals long battle ahead, experts say
Pharmaceutical giant says it's prepared to take case to the Supreme Court as it seeks to sidestep negotiation program
Coinbase, Apple stocks falls while GitLab, Thor shares rally, and other stocks on the move
Coinbase, Apple, GitLab and other stocks were among the most active on Tuesday.
Opinion Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays.
Big pharma will be looking to acquire companies with promising new medicines.
Corrected Moderna and Merck reveal new data on individualized cancer treatment
An investigational individualized neoantigen therapy studied in patients with high-risk melanoma is a collaboration between Moderna and Merck. A previous version of this article referred to it as Moderna’s therapy. Moderna...
Novo Nordisk in talks to buy controlling stake in Biocorp
Novo Nordisk NVO has entered into exclusive negotiations to acquire a controlling stake in French medical device maker Biocorp in a deal that values Biocorp at 154.4 million euros, or about $165 million, the companies said...
Day One Biopharmaceuticals shares jump 23% on positive results for glioma treatment
Day One Biopharmaceuticals DAWN shares climbed 23% in premarket trading Monday after the company shared new data on tovorafenib, an investigational treatment for relapsed or progressive pediatric low-grade glioma. Trial da...
Mallinckrodt evaluating another possible bankruptcy filing as $200 million opioid settlement pay comes due
Shares of Mallinckrodt PLC MNK tumbled 22.0% in premarket trading Monday, after the drug maker disclosed that certain debt holders proposed another bankruptcy filing given the company’s financial position. The proposal com...
Beyond OpenAI: 7 promising startups that have saved lives, sped up drug development and improved manufacturing
OpenAI is stealing the spotlight as the definitive AI startup, but other promising startups are making waves and generating buzz in Silicon Valley and beyond.
Retired doctor known as the ‘yellow man’ sentenced for selling toxic chemical as weight-loss drug that killed customer
Prosecutors say William Merlino also tried to fake a cancer diagnosis to delay his trial for selling DNP, a herbicide banned for human consumption.
Too much debt coming due and not much cash on hand: These 10 companies face a rough year ahead
Jefferies offers a list of the top 10 companies with low cash and high near-term debt maturities that investors should avoid.
Is your doctor downplaying your symptoms? How to stand up for yourself.
You need to advocate for yourself with your doctor. Here’s how to strike a balance between assertiveness and tact.
Eli Lilly releases new data on breast cancer, lymphoma treatments
Eli Lilly & Co. LLY on Friday released new clinical trial data on treatments for certain types of early breast cancer and mantle cell lymphoma. New analysis from a late-stage trial of Verzenio in node-positive, high risk e...
Medicare unveils plan for coverage of new Alzheimer’s drugs
Patient registry could be a barrier to coverage of new treatments, critics say.
RSV vaccine competition heats up as Pfizer’s shot for older adults gets FDA approval
Global market for RSV vaccine could reach $17 billion by 2033, analysts say.
Baseball legend Alex Rodriguez’s new pitch: Raising awareness about gum disease
Baseball great Alex Rodriguez — aka A-Rod — has an unlikely message for his fans and everyone else: He wants you to take better care of you gums.
10 stocks that will benefit from higher earnings on company cash, and 10 that have a debt problem
"Rates and yields are rising sharply in the U.S. and Europe, with both interest income and interest expense is set to rise, making cash the king," says Jefferies.
